• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study.BNT162b2 mRNA新冠疫苗接种后引发的免疫性血栓性血小板减少症：一项病例研究
Thromb Res. 2021 Dec;208:1-3. doi: 10.1016/j.thromres.2021.10.002. Epub 2021 Oct 9.
2
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].[BNT162b2 mRNA新冠疫苗接种后免疫性血小板减少症]
Rinsho Ketsueki. 2021;62(11):1639-1642. doi: 10.11406/rinketsu.62.1639.
3
[Severe thrombocytopenia after COVID-19 mRNA vaccination].[新冠病毒mRNA疫苗接种后出现严重血小板减少症]
Rinsho Ketsueki. 2021;62(12):1684-1687. doi: 10.11406/rinketsu.62.1684.
4
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].[BNT162b2 mRNA新冠疫苗接种后免疫性血小板减少症]
Rinsho Ketsueki. 2021;62(12):1688-1693. doi: 10.11406/rinketsu.62.1688.
5
Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.健康女性在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后发生广泛脑静脉窦血栓形成（CVST），但无血栓性血小板减少综合征（TTS）。
Am J Case Rep. 2022 Feb 9;23:e934744. doi: 10.12659/AJCR.934744.
6
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?BNT162B2 mRNA新冠疫苗在心肺移植年轻成年人中的应用：是否需要另一种严重急性呼吸综合征冠状病毒2免疫反应监测方法？
Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999.
7
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
8
Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.BNT162b2 mRNA新冠疫苗的皮肤反应
Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.
9
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.BNT162b2信使核糖核酸新冠疫苗诱发的冻疮样损伤强化了其与严重急性呼吸综合征冠状病毒2关系的假说。
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA新冠疫苗的安全性和有效性
N Engl J Med. 2021 Apr 22;384(16):1577. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.

引用本文的文献

1
How We Interpret Thrombosis with Thrombocytopenia Syndrome?我们如何解读血栓性血小板减少性紫癜？
Int J Mol Sci. 2024 May 1;25(9):4956. doi: 10.3390/ijms25094956.
2
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS).基于mRNA的新型冠状病毒2型疫苗（BNT162b2）接种后的血栓形成——是时候超越血小板减少综合征（TTS）相关血栓形成进行思考了。
Thromb Update. 2022 May;7:100104. doi: 10.1016/j.tru.2022.100104. Epub 2022 Apr 18.
3
Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report.BNT162b2 mRNA新冠疫苗加强针接种后引发的疫苗诱导免疫性血栓性血小板减少症：一例报告
Vaccines (Basel). 2023 Jun 19;11(6):1115. doi: 10.3390/vaccines11061115.
4
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
5
COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.COVID-19 疫苗接种与免疫后免疫和自身免疫不良事件的发生率：来自叙事文献综述的见解。
Front Immunol. 2022 Jul 5;13:872683. doi: 10.3389/fimmu.2022.872683. eCollection 2022.

本文引用的文献

1
No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.ChAdOx1 nCoV-19疫苗接种后抗PF4抗体与抗SARS-CoV-2抗体之间无相关性。
N Engl J Med. 2021 Sep 30;385(14):1334-1336. doi: 10.1056/NEJMc2111305. Epub 2021 Aug 25.
2
Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine.信使核糖核酸-1273疫苗接种后出现的血栓形成伴血小板减少症
Ann Intern Med. 2021 Oct;174(10):1480-1482. doi: 10.7326/L21-0244. Epub 2021 Jun 29.
3
Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology.针对 COVID-19 相关 VITT 的临床和实验室诊断建议：ISTH SSC 血小板免疫学小组委员会的交流。
J Thromb Haemost. 2021 Jun;19(6):1585-1588. doi: 10.1111/jth.15341. Epub 2021 May 20.
4
Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.接种 ChAdOx1 nCoV-19 和 BNT162b2 疫苗后抗 PF4/多阴离子抗体检测阳性的频率。
Blood. 2021 Jul 29;138(4):299-303. doi: 10.1182/blood.2021012217.
5
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.单剂 Ad26.COV2.S 疫苗预防新冠病毒的安全性和有效性。
N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.
6
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.严重急性呼吸综合征冠状病毒2型疫苗诱导的免疫性血栓性血小板减少症
N Engl J Med. 2021 Jun 10;384(23):2254-2256. doi: 10.1056/NEJMe2106315. Epub 2021 Apr 16.
7
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.Ad26.COV2.S疫苗接种后血栓性血小板减少症
N Engl J Med. 2021 May 20;384(20):1964-1965. doi: 10.1056/NEJMc2105869. Epub 2021 Apr 14.
8
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
9
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
10
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.一剂接种和加强针接种时间对 ChAdOx1 nCoV-19（阿斯利康）疫苗免疫原性和有效性的影响：四项随机试验的 pooled 分析。
Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19.

Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study.

作者信息

Rodríguez Carmen, Pérez-Nieva Alberto, Máiz Luis, Meijón María Del Mar, Llamas Pilar, Monreal Manuel, Bikdeli Behnood, Jiménez David

机构信息

Respiratory Department, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain.

Department of Internal Medicine, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain.

出版信息

Thromb Res. 2021 Dec;208:1-3. doi: 10.1016/j.thromres.2021.10.002. Epub 2021 Oct 9.

DOI:10.1016/j.thromres.2021.10.002
PMID:34649161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8501513/
Abstract
摘要